Ye’s deal to buy conservative social media app Parler is called off

Ye’s deal to buy conservative social media app Parler is called off


This illustration photo shows the Parler social network app logo on a cell phone screen with a picture of US rapper Kanye West in the background in Los Angeles, October 17, 2022.

Chris Delmas | AFP | Getty Images

Conservative social media company Parler said Thursday its deal to be bought by Ye has been called off.

The rapper, formerly known as Kanye West, agreed to buy the app in October for an undisclosed amount. Ye has made repeated and public antisemitic comments in recent months, and several business partnerships involving the musician have been terminated.

“The company has mutually agreed with Ye to terminate the intent of sale of Parler,” the app’s parent company said in a statement to CNBC. “This decision was made in the interest of both parties in mid-November. Parler will continue to pursue future opportunities for growth and the evolution of the platform for our vibrant community.”

Parler has attempted to position itself as a right-wing alternative to Twitter, which suspended Ye’s account shortly before he announced his intent to buy Parler.

“In a world where conservative opinions are considered to be controversial, we have to make sure we have the right to freely express ourselves,” Ye said at the time in a statement released by Parler.

Ye’s Twitter account has since been restored, and he’s continued to spread hateful comments toward Jewish people. Twitter’s new owner, Elon Musk, has emphasized the platform’s commitment to free speech.

Earlier this fall, retailers Gap and Adidas ended their dealings with Ye and his Yeezy clothing line. Ye expressed discontent with the partnerships, saying he wasn’t granted enough creative control over his fashion line.

This story is developing. Please check back for updates.

— CNBC’s Ryan Browne contributed to this report.



Source

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals
Business

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

Food and Drug Administration Commissioner Marty Makary warned that the U.S. is falling behind China in early-stage drug development and called for reforms that could streamline the process for starting trials on new treatments.  In an interview with CNBC on Wednesday, Makary specifically pointed to three bottlenecks that he said cause the U.S. to fall […]

Read More
Seattle Seahawks begin sale process after Super Bowl win
Business

Seattle Seahawks begin sale process after Super Bowl win

Dareke Young #83 of the Seattle Seahawks celebrates with teammates during the third quarter of the NFC Championship game against the Los Angeles Rams at Lumen Field on Jan. 25, 2026 in Seattle, Washington. Jane Gershovich | Getty Images The Seattle Seahawks are officially up for sale. The NFL team, which defeated the New England […]

Read More
FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive
Business

FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive

Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring – doubling down on a push that some in the pharmaceutical industry have questioned.  In an interview Wednesday in Washington, D.C., Makary said the FDA aims to make […]

Read More